| Cognition Pharmaceuticals LLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20100022658 | Methods for treating cognitive impairment in humans - Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. | 01-28-2010 |
| 20100010097 | Methods for treating mild cognitive impairment and alzheimer's disease - Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. | 01-14-2010 |
